Media headlines about Johnson Matthey (OTCMKTS:JMPLY) have been trending somewhat negative on Friday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Johnson Matthey earned a daily sentiment score of -1.00 on their scale. InfoTrie also assigned media coverage about the basic materials company an news buzz score of 10 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company’s share price in the near term.
These are some of the media headlines that may have effected Johnson Matthey’s ranking:
- Johnson Matthey tech to be used at new butanol facility in China (hl.co.uk)
- Palladium deficit expected to widen in 2020 – Johnson Matthey (markets.businessinsider.com)
- UPDATE 1-Palladium, rhodium deficits set to grow in 2020– Johnson Matthey (reuters.com)
- Palladium, platinum and rhodium markets all in deficit in 2019– Johnson Matthey (finance.yahoo.com)
- Is Now The Time To Look At Buying Johnson Matthey Plc (LON:JMAT)? (finance.yahoo.com)
Johnson Matthey stock opened at $70.00 on Friday. Johnson Matthey has a 12-month low of $66.88 and a 12-month high of $92.40. The company has a quick ratio of 0.90, a current ratio of 1.53 and a debt-to-equity ratio of 0.44. The business’s 50-day moving average price is $74.66 and its two-hundred day moving average price is $75.74. The stock has a market cap of $6.81 billion, a PE ratio of 11.74, a P/E/G ratio of 3.96 and a beta of 1.50.
The business also recently announced a Semi-Annual dividend, which will be paid on Friday, February 14th. Stockholders of record on Monday, December 2nd will be issued a $0.61 dividend. The ex-dividend date of this dividend is Friday, November 29th. Johnson Matthey’s dividend payout ratio (DPR) is currently 20.64%.
Several equities analysts have recently commented on JMPLY shares. ValuEngine cut shares of Johnson Matthey from a “hold” rating to a “sell” rating in a research report on Tuesday, November 19th. Zacks Investment Research raised shares of Johnson Matthey from a “sell” rating to a “hold” rating in a research note on Thursday, January 30th. Finally, JPMorgan Chase & Co. downgraded shares of Johnson Matthey from a “neutral” rating to an “underweight” rating in a research report on Thursday, November 28th. Three research analysts have rated the stock with a sell rating and two have assigned a hold rating to the stock. The company currently has an average rating of “Sell” and a consensus price target of $90.00.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Read More: Which market index is the best?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.